|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 21 to 25 of 25
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Miya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Cho, Kyu Yong; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Taguri, Masataka; Terauchi, Yasuo; Atsumi, Tatsuya | Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy : A randomized controlled trial | - | Journal of Diabetes Investigation | - | Jan-2018 |
| article | Takahashi, Kiyohiko; Cho, Kyu Yong; Nakamura, Akinobu; Miya, Aika; Miyoshi, Arina; Yamamoto, Chiho; Nomoto, Hiroshi; Niwa, Hirokatsu; Takahashi, Kiyohito; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Ito, Yoichi M; Atsumi, Tatsuya; Miyoshi, Hideaki | Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes | - | Journal of Diabetes Investigation | - | Mar-2019 |
| article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of Diabetes Investigation | - | Feb-2021 |
| article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of diabetes investigation | - | Feb-2021 |
| article | Cho, Kyu Yong; Nakamura, Akinobu; Oba-Yamamoto, Chiho; Tsuchida, Kazuhisa; Yanagiya, Shingo; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus : Randomized Controlled Trial | - | Diabetes & Metabolism Journal | - | 2019 |
Showing results 21 to 25 of 25
|
